Amlodipine/benazepril
Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva and Sandoz, is an antihypertensive medication which combines a calcium channel blocker (amlodipine besilate) with an angiotensin converting enzyme inhibitor (benazepril). This drug, like similar combinations, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.
Wikipage redirect
primaryTopic
Amlodipine/benazepril
Amlodipine/benazepril, marketed in the U.S. as Lotrel by Novartis and manufactured as a generic drug by Teva and Sandoz, is an antihypertensive medication which combines a calcium channel blocker (amlodipine besilate) with an angiotensin converting enzyme inhibitor (benazepril). This drug, like similar combinations, is prescribed when either agent alone is not sufficient to bring a person's blood pressure down to target range. As a combination agent, Lotrel shares the adverse reaction profile of both of its individual parts.
has abstract
Amlodipine/benazepril, markete ...... both of its individual parts.
@en
ATC prefix
CAS number
357437-90-2
PubChem
thumbnail
Link from a Wikipage to an external page
Wikipage page ID
Wikipage revision ID
743,881,843
ChemSpiderID
component
legal US
routes of administration
smiles
Clc1ccccc1C2C=CC.O=C[C@@H]CCc3ccccc3
StdInChIKey
SRTZYSFUFGOMFR-FKLPMGAJSA-N
Verifiedfields
verifiedrevid
415,479,203
hypernym
comment
Amlodipine/benazepril, markete ...... both of its individual parts.
@en
label
Amlodipine/benazepril
@en